Study of a Novel Multicomponent Meningococcal Group B Vaccine When Given Alone or With Other Licensed Vaccines in Adults, Adolescents, Toddlers and Infants

Clinical trial NCT04825223 · TERMINATED

Trial details

NCT number: NCT04825223
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Meningococcal Immunisation Healthy Volunteers

Start date: 2021-03-29
Primary completion: 2022-07-22
Enrollment: 576

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.